You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Live cell carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Renal Cell, NSCLC Trial in Belgium, France (Live Bacterial Product - Akkermansia muciniphila)

Recruiting
  • Carcinoma, Renal Cell
  • Carcinoma, Non-Small-Cell Lung
  • Live Bacterial Product - Akkermansia muciniphila
  • Mons, Belgium
  • +3 more
May 9, 2023

Transitional Cell Carcinoma Trial in New York (TICE®-strain BCG, NY-ESO-1 protein, sargramostim)

Completed
Has Results
  • Transitional Cell Carcinoma
  • TICE®-strain BCG
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Core needle biopsy
  • Madison, Wisconsin
    Elephas
Aug 4, 2022

NSCLC, Melanoma, Renal Cell Carcinoma Trial in Haifa (BMC128, Nivolumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Haifa, Israel
    Rambam MC
Aug 1, 2022

Oncology, Solid Tumor, Non Small Cell Lung Cancer Trial in United States (MRx0518, Pembrolizumab 25 MG/1 ML Intravenous Solution

Active, not recruiting
  • Oncology
  • +5 more
  • MRx0518
  • Pembrolizumab 25 MG/1 ML Intravenous Solution [KEYTRUDA]
  • Kansas City, Kansas
  • +4 more
Jul 5, 2022

Solid Tumor, Non Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck Trial in New Haven, Atlanta, Portland

Recruiting
  • Solid Tumor
  • +3 more
  • New Haven, Connecticut
  • +2 more
Aug 1, 2022

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Renal Cell Carcinoma Trial (Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Sep 11, 2023

Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
  • Qingdao, Shandong, China
  • +1 more
Nov 13, 2023

Delving Into Participation Trends in Renal Cell Carcinoma

Not yet recruiting
  • Renal Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

    Recruiting
    • Squamous Cell Carcinoma of Oral Cavity
    • +3 more
    • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
    • Gliwice, Silesia, Poland
      The Maria Sklodowska-Curie National Research Institute of Oncolo
    Aug 7, 2023

    Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Recruiting
    • Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 5, 2023

    Squamous Cell Carcinoma of Head and Neck, Basal Cell Carcinoma of Skin Trial in Vandœuvre-lès-Nancy (microscopy confocal

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Basal Cell Carcinoma of Skin
    • microscopy confocal (Histolog Scanner)
    • Vandœuvre-lès-Nancy, France
      Gilles Dolivet
    Jul 7, 2023

    Moesin Expression in Clear Cell Renal Cell Carcinoma

    Completed
    • Renal Cell Carcinoma
    • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
    • (no location specified)
    Sep 20, 2023

    Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

    Not yet recruiting
    • Squamous Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Jun 23, 2023

      Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 18, 2023

      Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • no intervention
      • Wuhan, Hubei, China
        Renmin hosptial of Wuhan University
      Jul 29, 2023

      Merkel Cell Carcinoma Clinical Trial Engagement Patterns

      Not yet recruiting
      • Merkel Cell Carcinoma
        • San Francisco, California
          Power Life Sciences
        Sep 8, 2023

        Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

        Not yet recruiting
        • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
        • Guangzhou, Guangdong, China
          Sun Yat-sen University
        Oct 24, 2023

        ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

        Not yet recruiting
        • ccRCC
        • +20 more
        • (no location specified)
        Jul 6, 2023

        Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

        Not yet recruiting
        • Metastatic Clear Cell Renal Cell Carcinoma
        • 68Ga-NY104 PET/CT
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        May 18, 2023

        Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 30, 2023

        Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

        Recruiting
        • Esophageal Squamous Cell Carcinoma
          • Shijiazhuang, Hebei, China
            Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
          Oct 25, 2023

          Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

          Not yet recruiting
          • Squamous Cell Carcinoma of the Skin
          • +2 more
          • Marlborough, Massachusetts
            Phio Pharmaceuticals Corp.
          Aug 25, 2023

          Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

          Completed
          • Huerthle Cell Carcinoma
            • (no location specified)
            Jul 20, 2023